Trials / Recruiting
RecruitingNCT06981767
Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus
Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus : A Randomized Clinical Trial
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 42 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Bromelain, an enzyme extract derived from pineapples, has shown promise due to its anti-inflammatory and wound-healing properties. However, its efficacy in treating oral mucosal ulcers remains unexplored. This study aims to provide clinical evidence on the efficacy of bromelain for managing OLP, potentially offering a safer and more effective treatment option.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Topical Bromelain | A natural enzyme-based formulation derived from pineapple, bromelain in orabase is being investigated for its anti-inflammatory and wound-healing properties. As a non-steroidal alternative, it offers a potentially safer treatment option with minimal side effects. |
| DRUG | 0.1% topical triamcinolone acetonide | A corticosteroid-based standard treatment for OLP, triamcinolone acetonide in orabase is used for its strong anti-inflammatory and immunosuppressive effects. It serves as the conventional treatment versus novel therapy in this study |
| COMBINATION_PRODUCT | Combination of Topical Bromelain and Triamcinolone Acetonide in Orabase | This novel formulation combines the enzymatic, healing properties of bromelain with the anti-inflammatory property of triamcinolone. It is designed to provide enhanced therapeutic effects through synergistic action, potentially reducing the required corticosteroid dose while improving clinical outcomes. |
Timeline
- Start date
- 2026-02-18
- Primary completion
- 2026-05-15
- Completion
- 2026-06-15
- First posted
- 2025-05-21
- Last updated
- 2026-03-03
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06981767. Inclusion in this directory is not an endorsement.